Top Markets
Coin of the day
W World Corp. W World Corp.

W World Corp.

WWHC
Rangering i aksjer #22981
W World Corp. is a biopharmaceutical firm dedicated to identifying and... W World Corp. is a biopharmaceutical firm dedicated to identifying and advancing innovative treatments for various metabolic and neurological conditions. Its research and development efforts specifically target ailments related to the brain-gut axis, pain and inflammation, autoimmune diseases, and gout. The company's pipeline features two primary experimental drugs: Levotofisopam, currently in clinical trials as a non-sedative therapy for Gout, and Dextofisopam, a non-serotonergic compound that has successfully concluded Phase IIa and Phase IIb clinical trials for irritable bowel syndrome (IBS). Established in 1990, W World Corp. maintains its corporate headquarters in North Las Vegas, Nevada.
Aksjekurs
$0.8
Sist synkronisert: 2024-01-02
Markedsverdi
$80.24M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel W World Corp. (WWHC)
P/S-forhold for W World Corp. (WWHC)
P/S-forhold per 2026 TTM: 0
Ifølge W World Corp. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for W World Corp. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter